Acute Heart Failure - Epidemiology - Epidemiology Dashboard

Clarivate Epidemiology’s coverage of heart failure (HF) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report both the diagnosed event rates of AHF and the diagnosed prevalence of CHF for each country, as well as annualized case counts projected to the national population.

Most patient populations are forecast over a period of 20 years for the mature markets and Europe and 10 years for the other countries we cover.

All forecast data are available on Clarivate’s Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.

Clarivate Epidemiology’s HF forecast answers the following questions:

In developing countries, what impact will economic growth and development have on the number of people diagnosed with severe disease?
Of all AHF hospitalization events, how many in each of the major mature pharmaceutical markets are drug-treated?
Of all people diagnosed with CHF, how many in each of the major mature pharmaceutical markets are drug-treated?
How will demographic trends such as population aging and improving life expectancy affect the epidemiology of HF over the forecast period?

In addition to the total number of cases for each forecast year, Clarivate Epidemiology provides at least 10 years of forecast data for the following HF subpopulations:

Diagnosed AHF events by ejection fraction.
Diagnosed AHF events by treatment status.
Diagnosed AHF events by subpopulation.
Diagnosed CHF prevalent cases by severity.
Diagnosed CHF prevalent cases by treatment scheme.
Diagnosed CHF prevalent cases by ejection fraction.
Diagnosed CHF prevalent cases by comorbidity.

Note: Coverage may vary by country.

Acute Heart Failure - Epidemiology - Epidemiology Dashboard
- Introduction
  - Heart Failure Epidemiology Dashboard

Contact sales account_box

Report

Eosinophilic Esophagitis – Current Treatment – Treatment Algorithms: Claims Data Analysis – Eosinophilic Esophagitis (US)

Eosinophilic esophagitis (EoE) is a chronic allergic inflammatory condition of the esophagus, marked by an accumulation of eosinophils. This can lead to difficulty swallowing and potentially…

north_east

Report

Atrial Fibrillation – Current Treatment – Treatment Algorithms: Claims Data Analysis – Atrial Fibrillation (US)

Atrial fibrillation (AF) is a common arrhythmia characterized by irregular, often rapid heartbeats in the atria, increasing the risk of stroke and cardiovascular complications. Management typically…

north_east

Report

Type 2 Diabetes – Current Treatment – Detailed, Expanded Analysis: Treatment Algorithms: Claims Data Analysis (US)

Metformin remains the most heavily prescribed type 2 diabetes (T2D) drug and dominates the early lines of therapy before disease progression requires insulin replacement. More effective, safer, and…

north_east

Report

Multiple Sclerosis – Current Treatment – Treatment Algorithms: Claims Data Analysis – Multiple Sclerosis (US)

The treatment landscape for multiple sclerosis (MS) in the U.S. is rapidly evolving, with over 20 immunomodulatory disease-modifying therapies (DMTs) available and more in development. The market…

north_east

Report

Major Depressive Disorder (DSM-V) – Current Treatment – Treatment Algorithms: Claims Data Analysis – Major Depressive Disorder (US)

Major depressive disorder (MDD) is a condition heavily treated with an array of drug classes. Although the MDD drug market is dominated by generic therapies, the heterogeneous response of MDD…

north_east

Product logins

Acute Heart Failure – Epidemiology – Epidemiology Dashboard

Table of contents

Related Market Assessment Reports

Eosinophilic Esophagitis – Current Treatment – Treatment Algorithms: Claims Data Analysis – Eosinophilic Esophagitis (US)

Atrial Fibrillation – Current Treatment – Treatment Algorithms: Claims Data Analysis – Atrial Fibrillation (US)

Type 2 Diabetes – Current Treatment – Detailed, Expanded Analysis: Treatment Algorithms: Claims Data Analysis (US)

Multiple Sclerosis – Current Treatment – Treatment Algorithms: Claims Data Analysis – Multiple Sclerosis (US)

Major Depressive Disorder (DSM-V) – Current Treatment – Treatment Algorithms: Claims Data Analysis – Major Depressive Disorder (US)

Follow us

Contact us